As someone who has spent decades watching the healthcare supply chain adapt to new realities, I can say the 2026 State of Healthcare Supply Chain Survey confirms a shift many of us anticipated: disruptions and cost pressures have settled in as dual top challenges. With persistent volatility in product availability and continued margin pressures across health systems, these two forces now shape every supply chain strategy, often at the same time.
What also stands out this year is a clear softening in leader sentiment. More respondents expect supply chain challenges to worsen rather than improve in the coming year—a sober but realistic assessment given the operational strain many teams continue to face. This cautious outlook isn’t driven by pessimism for its own sake, but by a practical understanding: volatility is not fading, and savings expectations continue to rise.
Below are the key takeaways I believe matter most as we prepare for 2026.
1. The era of the dual challenge has arrived, naturally and predictably
The survey shows that disruptions and cost savings now share the top spot as supply chain’s most significant challenges. Rather than a surprising shift, this reflects a logical evolution. Supply chain disruptions haven’t eased, and in many areas, they have intensified, particularly for specialized and clinically sensitive products. At the same time, savings targets continue to rise as organizations work to stabilize financial performance.
These pressures are intertwined. Persistent backorders, discontinuations, and sourcing complexity make it harder for teams to negotiate or sustain lower prices. Meanwhile, inflation and margin pressures demand that savings efforts continue. In short: cost efforts are more important than ever, but are also more difficult than ever.
The message for 2026 is clear: we must manage both the financial and operational sides of supply chain with equal discipline.
2. Clinical collaboration is weakening, and this may be the most concerning trend
As I feared, and reluctantly predicted, we have swung back toward pre-COVID levels of clinician disengagement. Only a small fraction of leaders “strongly agree” that clinicians are supportive of supply chain activities. Clinical integration appears structurally present in most organizations, but not deeply rooted or consistently practiced.
For supply chain leaders, this is more than a relational concern. It impacts:
- Standardization efforts
- Utilization improvement
- New product governance
- Ability to evaluate products using evidence rather than preference
We will not achieve meaningful progress on cost, quality, or outcomes unless we re-establish clinicians as core partners. The good news: the work to rebuild collaboration does not require reinventing the process; it requires going back to the basics—structured governance, evidence-based evaluation, and transparent data shared in partnership.
Discover the top pain points & opportunities identified by healthcare supply chain leaders
Nearly 100 supply chain leaders across U.S. hospitals and health systems provided their insights.
View infographic
3. The priorities for 2026 reflect a more balanced, value-driven mandate
While cost savings again tops the list of organizational priorities, the survey shows that improving patient outcomes and standardizing processes sit closely behind, followed by reducing unnecessary utilization. This balance is encouraging. Supply chain teams increasingly recognize that savings, resiliency, and outcomes are interconnected, not competing goals.
This year’s responses suggest that the most effective teams are those grounding their strategy in fundamentals:
- Clear processes
- Strong clinical relationships
- Evidence-based decision frameworks
- Reliable, transparent data
- A disciplined approach to utilization
These basics create the structure that allows organizations to absorb volatility while still moving strategic work forward.
4. Getting ahead in 2026 means going back to the fundamentals
If there is a single theme I want supply chain leaders to take from this year’s findings, it’s this:
We succeed in 2026, not by adding complexity, but by returning to disciplined fundamentals.
That includes:
- Make clinical collaboration routine, not optional
Rebuild trust and alignment. Bring clinicians into conversations early, consistently, and with shared goals around outcomes and stewardship. - Use evidence and benchmarking in every product decision
A standardized, transparent evaluation process grounded in clinical evidence, comparative cost, and clear criteria reduces variation and strengthens governance. - Strengthen processes before expanding tools
Standardized intake, clear workflows, and consistent decision-making frameworks reduce rework and help teams reclaim time. - Shift savings strategy toward utilization and variation management
Price will always be part of the equation, but in a volatile environment, utilization often offers greater and more sustainable impact. - Embed resiliency thinking into everyday operations
Risk stratification, supplier partnerships, and proactive planning ensure that daily disruptions don’t erode strategic progress and help reduce the operational burden that fuels leader pessimism.
These fundamentals are not new, but they are more essential than ever.
Looking forward
This year’s survey shows a supply chain that understands what it must do—balance financial expectations, operational realities, and clinical outcomes—and is actively trying to move in that direction. But it also reveals a field that needs to reclaim time, strengthen clinical partnership, and re-establish disciplined processes to make that progress possible.
As we step into 2026, my message to supply chain leaders is simple:
Steady the foundation, rebuild collaboration, and do the basics exceptionally well. That is how we create a more resilient, efficient, and outcome-minded supply chain, no matter what disruptions or pressures lie ahead.
